John Horvath

John Horvath is a seasoned financial professional currently serving as a Partner at EisnerAmper since January 2020. In addition, John holds a position on the Board of Directors and is involved in capital raising efforts at Mononuclear Therapeutics, a Hong Kong-based cell therapy startup led by Dr. Wise Young. Previously, John was the President of Horvath & Giacin, P.C., a New Jersey CPA firm that operated for over 30 years, providing accounting and advisory services globally. John also contributed as a Board Member in capital raising at RobustWealth, a financial technology company, and played a key role as a Founding Member and Initial Capital Raise for The Bank of Princeton, established in 2007. John holds a Bachelor's degree in Accounting from Rider University.